Connect Biopharma Holdings Limited Entity Listing, Depository Receipt Ratio
Connect Biopharma Holdings Limited (CNTB) had Entity Listing, Depository Receipt Ratio of 100.00% as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Cover Page
dei:EntityListingDepositoryReceiptRatio · last filed 2025-08-13
- 2025-06-30: Entity Listing, Depository Receipt Ratio 100.00%.
- 2025-03-31: Entity Listing, Depository Receipt Ratio 100.00%.
- 2024-12-31: Entity Listing, Depository Receipt Ratio 100.00%.
| Period end | Entity Listing, Depository Receipt Ratio |
|---|---|
| 2025-06-30 | 100.00% 10-Q · filed 2025-08-13 |
| 2025-03-31 | 100.00% 10-Q · filed 2025-05-15 |
| 2024-12-31 | 100.00% 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |